false 0001156375 0001156375 2024-05-09 2024-05-09

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported)

May 13, 2024 (May 9, 2024)

 

 

CME GROUP INC.

(Exact Name of Registrant as Specified in Charter)

 

 

 

Delaware   001-31553   36-4459170

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File No.)

 

(IRS Employer

Identification No.)

20 South Wacker Drive

Chicago, Illinois 60606

(Address of Principal Executive Offices) (Zip Code)

Registrant’s telephone number, including area code: (312) 930-1000

N/A

(Former Name or Former Address, if Changed Since Last Report)

 

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

symbol

 

Name of each exchange

on which registered

Class A Common Stock   CME   Nasdaq

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 


Item 5.07.

Submission of Matters to a Vote of Security Holders.

CME Group Inc. (the “Company”) held its 2024 Annual Meeting of Shareholders on May 9, 2024 (the “Annual Meeting”).

At the close of business on March 11, 2024, the record date of the Annual Meeting, the Company had 360,025,217 shares of Class A and Class B common stock issued and outstanding. The following shares were present at the Annual Meeting, either in person at the virtual shareholder meeting or by proxy.

 

Class(es) of Common Stock

   Aggregate No. of
Shares
     % of the Issued and
Outstanding
 

Classes A and B

     314,467,507        87.34

Class B-1

     108        17.28

Class B-2

     156        19.19

Class B-3

     186        14.45

Class B-4

     80        14.04

The results of the proposals are as follows:

 

  1.

The election of seventeen Equity Directors to serve until 2025 (elected by the Class A and Class B shareholders voting together as a single class):

 

Name

   Votes For      Against      Abstain  

Terrence A. Duffy

     264,576,518        23,927,907        2,198,870  

Kathryn Benesh

     287,025,625        3,377,766        299,904  

Timothy S. Bitsberger

     271,199,149        18,826,377        677,769  

Charles P. Carey

     250,175,640        38,943,118        1,584,537  

Bryan T. Durkin

     276,236,227        14,134,156        332,912  

Harold Ford Jr.

     286,905,347        3,543,234        254,714  

Martin J. Gepsman

     245,526,452        44,777,087        399,756  

Larry G. Gerdes

     258,928,745        31,252,047        522,503  

Daniel R. Glickman

     247,915,795        41,955,656        831,844  

Daniel G. Kaye

     281,647,502        8,734,716        321,077  

Phyllis M. Lockett

     186,404,669        103,767,613        531,013  

Deborah J. Lucas

     286,554,619        3,804,978        343,698  

Terry L. Savage

     262,369,321        27,634,626        699,348  

Rahael Seifu

     279,119,772        10,896,682        686,841  

William R. Shepard

     265,731,090        24,770,177        202,028  

Howard J. Siegel

     265,983,505        24,482,362        237,428  

Dennis A. Suskind

     242,126,932        48,090,239        486,124  

There were a total of 23,764,212 broker non-votes in this proposal.


  2.

The ratification of the appointment of Ernst & Young LLP as the Company’s independent public accounting firm for 2024 (ratified by the Class A and Class B shareholders voting together as a single class):

 

Votes For

 

Votes Against

 

Abstentions

289,766,319   24,482,330   218,858

 

  3.

The advisory vote of the compensation of the Company’s named executive officers (by the Class A and Class B shareholders voting together as a single class) was approved:

 

Votes For

 

Votes Against

 

Abstentions

253,068,323   37,272,265   362,707

There were a total of 23,764,212 broker non-votes in this proposal.

 

  4.

The election of Class B Directors:

 

  a.

In the election of the three Class B-1 Directors, no quorum was achieved. Therefore, William W. Hobert, Patrick J. Mulchrone and Robert J. Tierney Jr. are each a “holdover” under Delaware law and the Company’s bylaws. They will continue to serve until their successors are duly elected at the 2025 Annual Meeting or their earlier resignation or removal.

 

Name

   Votes For      Votes Against      Abstentions  

William W. Hobert

     97        7        4  

Patrick J. Mulchrone

     102        3        3  

Robert J. Tierney Jr.

     101        5        2  

 

  a.

In the election of the two Class B-2 Directors, no quorum was achieved. Therefore, Michael G. Dennis and Patrick W. Maloney are each a “holdover” under Delaware law and the Company’s bylaws. They will continue to serve until their successors are duly elected at the 2025 Annual Meeting or their earlier resignation or removal.

 

Name

   Votes For      Votes Against      Abstentions  

Michael G. Dennis

     132        16        8  

Patrick W. Maloney

     142        10        4  


  b.

In the election of one Class B-3 Director, no quorum was achieved. Therefore, Elizabeth A. Cook is a “holdover” under Delaware law and the Company’s bylaws. She will continue to serve until her successor is duly elected at the 2025 Annual Meeting or her earlier resignation or removal.

 

Name

   Votes For      Votes Against      Abstentions  

Elizabeth A. Cook

     157        26        3  


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    CME Group Inc.
    Registrant
Date: May 13, 2024     By:  

/s/ Jonathan Marcus

    Name:   Jonathan Marcus
    Title:   Senior Managing Director and General Counsel
v3.24.1.1.u2
Document and Entity Information
May 09, 2024
Cover [Abstract]  
Amendment Flag false
Entity Central Index Key 0001156375
Document Type 8-K
Document Period End Date May 09, 2024
Entity Registrant Name CME GROUP INC.
Entity Incorporation State Country Code DE
Entity File Number 001-31553
Entity Tax Identification Number 36-4459170
Entity Address, Address Line One 20 South Wacker Drive
Entity Address, City or Town Chicago
Entity Address, State or Province IL
Entity Address, Postal Zip Code 60606
City Area Code (312)
Local Phone Number 930-1000
Security 12b Title Class A Common Stock
Trading Symbol CME
Security Exchange Name NASDAQ
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Entity Emerging Growth Company false

CME (NASDAQ:CME)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024 CME 차트를 더 보려면 여기를 클릭.
CME (NASDAQ:CME)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024 CME 차트를 더 보려면 여기를 클릭.